Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Wellgen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Wellgen

Wellgen

WellGen, Inc. is a biotech firm using nutrigenomics to develop proprietary natural products for therapeutic and dietary use.

HQ
North Brunswick, NJ, US
Founded
1997
Overview
Compare
Fundraising
Employees

WellGen, Inc. is a biotechnology firm leveraging nutrigenomics to create proprietary natural products for therapeutic and dietary applications. Their core product, Alignomx™, is a bioinformatics model that utilizes gene expression data to identify optimal therapeutic areas for their pipeline. WellGen focuses on the intersection of food and pharmaceuticals, aiming to develop medical foods with significant health benefits.

WellGen has made notable strides in the biotech industry by integrating advanced nutrigenomics and natural product chemistry. Their innovative approach has positioned them as a leader in developing effective medical foods. The company's impact is reflected in its growing pipeline of products designed to improve health outcomes through natural means.

Wellgen - Similar Companies

LifeNome logo

LifeNome

PanGenX logo

PanGenX

Geneicd logo

Geneicd

GenieBiome logo

GenieBiome

Novogenia logo

Novogenia

novogenia.com

Genexa logo

Genexa

genexa.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Genomenon logo

Genomenon

genomenon.com

IngateyGen logo

IngateyGen

ingateygen.com

Genome Insight logo

Genome Insight

Adipogenix logo

Adipogenix

Inform Genomics logo

Inform Genomics

informgenomics.com

General Genomics logo

General Genomics

ggenomics.com

Complegen logo

Complegen

Conagen logo

Conagen

Wellgen - Quick Facts

Who are Wellgen's competitors?

Companies similar to Wellgen include LifeNome, PanGenX, Geneicd and GenieBiome.

When was Wellgen founded?

Wellgen was founded in 1997.

Where is Wellgen's headquarters located?

Wellgen's headquarters is located in North Brunswick, NJ, US.

When was Wellgen's last funding round?

Wellgen's most recent funding round was for $9.5M (USD) in October 2007.

How much has Wellgen raised to-date?

As of Oct 29, 2007, Wellgen has raised a total of $16.5M (USD).

How many employees does Wellgen have?

Wellgen has 30 employees as of Feb 5, 2024.

Wellgen - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Natural Products
Tags
  • Data Information
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified